Celastrol (NSC 70931)

Catalog No.S1290 Synonyms: Tripterine

For research use only.

Celastrol (NSC 70931, Tripterine) is a potent proteasome inhibitor for the chymotrypsin-like activity of a purified 20S proteasome with IC50 of 2.5 μM. Celastrol induces apoptosis and autophagy via the ROS/JNK signaling pathway. Celastrol inhibits dopaminergic neuronal death of Parkinson's disease through activating mitophagy.

Celastrol (NSC 70931) Chemical Structure

CAS No. 34157-83-0

Selleck's Celastrol (NSC 70931) has been cited by 9 Publications

2 Customer Reviews

Purity & Quality Control

Choose Selective Proteasome Inhibitors

Other Proteasome Products

Biological Activity

Description Celastrol (NSC 70931, Tripterine) is a potent proteasome inhibitor for the chymotrypsin-like activity of a purified 20S proteasome with IC50 of 2.5 μM. Celastrol induces apoptosis and autophagy via the ROS/JNK signaling pathway. Celastrol inhibits dopaminergic neuronal death of Parkinson's disease through activating mitophagy.
Features A potent antioxidant and anti-inflammatory drug.
Targets
20S proteasome [1]
(Cell-free assay)
2.5 μM
In vitro

Celastrol at 5 μM inhibits the chymotrypsin-like, PGPH-like, and trypsin-like activities of the purified 20S proteasome by 80%, 5%, and <1%, respectively, whereas at 10 μM, it inhibits these three proteasomal activities by ∼90%, 15%, and <1%, respectively. Celastrol significantly inhibits the proteasomal chymotrypsin activity in PC-3 cells in a concentration-dependent manner. Celastrol at 2.5 μM to 5 μM induces caspase-3 activity by 4.7-fold to 5.5-fold in PC-3 cells. Celastrol (5 μM) treated cells, the levels of the proteasome target proteins, IκB-α and Bax, are increased after 1 hour and further increased to its peak for 4 hours to 12 hours. Celastrol (2.5 μM) treatment induces proteasome inhibition by 40%, as shown by the decreased levels of chymotrypsin-like activity and increased accumulation of ubiquitinated proteins in LNCaP cells. Celastrol (2.5 μM) induces apoptosis in the Celastrol-treated LNCaP cells, as shown by increased levels of caspase-3 activity (up to 3.5-fold), PARP cleavage, and apoptotic morphology. [1] Celastrol (300 nM) is found to suppress LPS-induced production of TNF-alpha and IL-1beta by human monocytes and macrophages. Celastrol (100 nM) also decreases LPS-induced expression of class II MHC molecules by microglia. Celastrol strongly inhibits LPS and IFN-y-induced NO production with IC50 of 200 nM in macrophage lineage cells. Celastrol strongly inhibits TNF-α and IFN-γ-induced NO production with IC50 of 200 nM in endothelial cells. [2] Celastrol (2.5 μM) potentiates the apoptosis induced by TNF and chemotherapeutic agents and inhibits invasion, both regulated by NF-kappaB activation, in KBM-5 cells. Celastrol (2.5 μM) suppresses the expression of TNF induced the expression of gene products involved in antiapoptosis (IAP1, IAP2, Bcl-2, Bcl-XL, c-FLIP, and survivin), proliferation (cyclin D1 and COX-2), invasion (MMP-9), and angiogenesis (VEGF) in KBM-5 cells. Celastrol (5 μM) is found to inhibit the TNF-induced activation of IkappaBalpha kinase, IkappaBalpha phosphorylation, IkappaBalpha degradation, p65 nuclear translocation and phosphorylation, and NF-kappaB-mediated reporter gene expression. [3] Celastrol inhibits proliferating of RPMI 8226, KATOIII, UM-SCC1, U251MG and MDA-MB-231 cells with IC50 of 0.52 μM, 0.54 μM, 0.76 μM, 0.69 μM and 0.67 μM, respectively. Celastrol (1 μM) inhibits growth of RPMI 8226 with a decrease in the levels of cyclin D1 and cyclin E, but concomitant increase in the levels of p21 and p27. Celastrol induces apoptosis in RPMI-8226 cells indicated by the activation of caspase-8, bid cleavage, caspase-9 activation, caspase-3 activation, PARP cleavage and through the down regulation of anti-apoptototic proteins. Celastrol (1 μM) suppresses Akt pathway and activates JNK kinase in RPMI-8226 cells. [4]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
RAW264.7 M4TaO2FvfGmrbn\sZY1u[XSxcomgZZN{[Xl? M4XudFI1KGi{cx?= NY\Vd3hWSW62aXnu[oxidW2jdH;yfUBi[3Srdnn0fUBi\2GrboP0JI1wfXOnIGLBW|I3PC55IHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4YhVFCVLXnu[JVk\WRiTl:gdJJw\HWldHnvckB1emWjdHXkJFMhcHK|IHLl[o9z\SCOUGOgZ4hidGynbnflJIF{e2W|c3XkJIFnfGW{IEK0JIhzeyCkeTDHdolme3NicnXh[4VvfCCjc4PhfUwhUUN3MDC9JFAvOjNizszNMi=> MlzLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTF6MEmwO|YoRjFzOEC5NFc3RC:jPh?=
RAW264.7 MWjBcpRqcW6obHHtcYF1d3K7IHHzd4F6 NWrE[FN7OjRiaILz NXr4SXZuSW62aXnu[oxidW2jdH;yfUBi[3Srdnn0fUBi\2GrboP0JI1wfXOnIGLBW|I3PC55IHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4YhVFCVLXnu[JVk\WRiTl[tb4FxeGGEIHHjeIl3[XSrb36geJJm[XSnZDCzJIhzeyCkZX\vdoUhVFCVIHPoZYxt\W6pZTDhd5Nme3OnZDDh[pRmeiB{NDDodpMh[nliU1XBVEBz\XCxcoTldkBo\W6nIHHzd4F6NCCLQ{WwJF0hOC5{NzFOwG0v NGDhWWE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zMUiwPVA4Pid-MUG4NFkxPzZ:L3G+
RPMI8226 MYfHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MkL0S5Jwf3SqIHnubIljcXSrb36gc4YhcHWvYX6gVnBOUTh{Mk[gZ4VtdHNuIFnDOVAhRSB|IN88UU4> MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDF4NEG5O{c,OThzNkSxPVc9N2F-
HeLa NFjiSFhHfW6ldHnvckBie3OjeR?= MXHJcohq[mm2aX;uJI9nKFSQRj3hcJBp[S2rbnT1Z4VlKE6ILXvhdJBiSiCjY4TpeoF1cW:wIHnuJIh2dWGwIFjlUIEh[2WubIOgZpkhW0WDUDDy[ZBwenSncjDn[Y5mKGG|c3H5MEBKSzVyIE2gNE4yPSEQvF2u NWDnXHU4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi4OFE6ODZpPkG4PFQyQTB4PD;hQi=>
RAW264.7 MY\GeY5kfGmxbjDhd5NigQ>? Mn\uTY5pcWKrdHnvckBw\iCOUGOtbY5lfWOnZDDOSk1s[XCyYVKgZYN1cX[jdHnvckBqdiCvb4Xz[UBTSVd{NkSuO{Bk\WyuczDifUBUTUGSIILldI9zfGW{IHflcoUh[XO|YYmsJGlEPTBiPTCwMlMh|ryPLh?= NU[ycHI4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi4OFE6ODZpPkG4PFQyQTB4PD;hQi=>
SH-SY5Y NID1TJhHfW6ldHnvckBie3OjeR?= MWPO[ZVzd3C{b4TlZ5Rqd25iYXfhbY5{fCCkZYThMYFugWyxaXSgdIVxfGmmZTCxMVQzNWmwZIXj[YQhfG:6aXPpeJkhcW5iaIXtZY4hW0hvU2m1XUBk\WyuczDhd5Nme3OnZDDhd{Bt[WO2YYTlJIRmcHmmcn;n[Y5ie2VicnXs[YF{\SxiRVO1NEA:KDBwMEO3OlQh|ryPLh?= MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTF|OEi1PUc,OTlzM{i4OVk9N2F-
HeLa M{njV2Z2dmO2aX;uJIF{e2G7 NEnwNpczKGi{cx?= MYHBcZBtcW[rY3H0bY9vKG:oIFjTSlEhfHKjboPjdolxfGmxbnHsJIFkfGm4aYT5JIlvKGi3bXHuJIhm[XRic3jvZ4sucW6mdXPl[EBJ\UyjIHPlcIx{KGG|c3Xzd4VlKGG|IHfyZY52dGViZn;ycYF1cW:wIITy[YF1\WRiMTDodkBj\W[xcnWgbIVifCC|aH;jb{BkcGGubHXu[4UhdWWjc4Xy[YQh[W[2ZYKgNkBpenNid3n0bI92fCC{ZXPveoVzgSC2aX3lJIJ6KGmvbYXuc4N6fG:laHXtbYNidCC|dHHpcolv\yxiRVO1NEA:KDFwMTFOwG0v MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTVyMkC1O{c,OTl3MEKwOVc9N2F-
SK-N-SH MXjDfZRwfG:6aXPpeJkh[XO|YYm= MV63NkBpenN? NHHPfWZEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBUUy2QLWPIJINmdGy|IHHmeIVzKDd{IHjyd{BjgSCPVGOgZZN{[XluIFPDOVAhRSBzLk[g{txONg>? MXm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTVyMkC1O{c,OTl3MEKwOVc9N2F-
HeLa MnnzSpVv[3Srb36gZZN{[Xl? NVTTXZRXOyCqcoO= MkT0RY1xdGmoaXPheIlwdiCxZjDIV2YyKHS{YX7zZ5JqeHSrb37hcEBi[3Srdnn0fUBqdiCqdX3hckBJ\UyjIHPlcIx{KGG|c3Xzd4VlKGG|IHfyZY52dGViZn;ycYF1cW:wIIDy[ZRz\WG2ZXSg[o9zKDNiaILzJIJ6KGmvbYXuc4N6fG:laHXtbYNidCC|dHHpcolv\yxiRVO1NEA:KDJwNjFOwG0v Ml\WQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl3MEKwOVcoRjF7NUCyNFU4RC:jPh?=
HeLa NX3jcYtNS3m2b4TvfIlkcXS7IHHzd4F6 MmGwO|IhcHK| M3ewNWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhmVGFiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JG1VWyCjc4PhfUwhS0N3MDC9JFMh|ryPLh?= NH\2SHU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUWwNlA2Pyd-MUm1NFIxPTd:L3G+
HeLa NFzMXW1HfW6ldHnvckBie3OjeR?= NUGxOmhHUW6qaXLpeIlwdiCxZjDOSk1s[XCyYVKgZYN1cX[rdImgbY4hcHWvYX6gTIVN[SClZXzsd{BjgSCVRVHQJJJmeG:{dHXyJIF{e2G7LDDJR|UxKD1iMD6xOUDPxE1w Ml7FQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjB2Nkm4PFcoRjJyNE[5PFg4RC:jPh?=
LNCAP MW\BcpRqfHWvb4KgZZN{[Xl? NXywTW52SW62aYT1cY9zKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gUG5ESVBiY3XscJMtKEmFNUCgQUAzNjVizszNMi=> MXq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODZ{N{W1Okc,OjB4Mke1OVY9N2F-
PC12 M4DPSGN6fG:ycn;0[YN1cX[nIHHzd4F6 MUTDfZRweHKxdHXjeIl3\SCjY4Tpeol1gSCjZ3HpcpN1KHRvQmDIMYlv\HWlZXSgZ4VtdCCmYX3h[4UhcW5icnH0JHBEOTJiY3XscJMh[XO|ZYPz[YQh[XNiY3XscEB3cWGkaXzpeJktKEmFNUCgQUA{NjF3IN88UU4> NVHhfmNGRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkC2Nlc2PTZpPkKwOlI4PTV4PD;hQi=>
PC12 NIj1dYlEgXSxcILveIVkfGm4ZTDhd5NigQ>? NUDRd2w{OS54IIXN M1\BbWN6fG:ycn;0[YN1cX[nIHHjeIl3cXS7IHHnZYlve3RidD3CVGgucW6mdXPl[EBk\WyuIHThcYFo\SCrbjDyZZQhWENzMjDj[YxteyCjc4Pld5Nm\CCjczDj[YxtKH[rYXLpcIl1gSCjdDCxMlYhfU1? NFHPb4c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{ME[yO|U2Pid-MkC2Nlc2PTZ:L3G+
THP1 MW\BdI9xfG:|aYOgZZN{[Xl? M{LO[VI1KGi{cx?= NHnwd|ZKdmS3Y4Tpc44hd2ZiYYDvdJRwe2m|IHnuJHRTSUmOLYLld4l{fGGwdDDoeY1idiCWSGCxJINmdGy|IHHmeIVzKDJ2IHjyd{BjgSCjbn7lfIlvNVZic4ThbY5qdmduIFXDOVAhRSBzNTFOwG0v MkXRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjB6NkSzOFIoRjJyOE[0N|QzRC:jPh?=
293T NV60b2Q5TnWwY4Tpc44h[XO|YYm= MWmzNEBucW6| Mn3KTY5pcWKrdHnvckBw\iCOUGOtbY5lfWOnZDDOSk1s[XCyYVKgZYN1cX[jdHnvckBqdiCqdX3hckAzQTOWIHPlcIx{KGmwY4XiZZRm\CCob4KgN|AhdWmwczDmc4xtd3enZDDifUB1emWjdHXkJJdqfGhiTGDTJIZweiB4IHjyd{BjgSCmdXHsMYx2[2moZYLhd4UhemWyb4L0[ZIh[XO|YYmsJGlEPTBiPTCwMlE4KM7:TT6= NV7vd3Z4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGzPVMxODRpPkKxN|k{ODB2PD;hQi=>
293T NELJO3NEgXSxdH;4bYNqfHliYYPzZZk> NXTreZpqS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hOjl|VDDj[YxteyCjc4Pld5Nm\CCjczDj[YxtKH[rYXLpcIl1gSCkeTDkeYFtNWy3Y3nm[ZJie2VicnXwc5J1\XJiYYPzZZktKEmFNUCgQUAxNjZ5IN88UU4> MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTN7M{CwOEc,OjF|OUOwNFQ9N2F-
RAW264 NGfjV|VHfW6ldHnvckBie3OjeR?= MXSyOEBpenN? MWrJcohq[mm2aX;uJI9nKEySUz3pcoR2[2WmIF7PJJBzd2S3Y4Tpc44hcW5ibX;1d4UhWkGZMk[0JINmdGy|IHHmeIVzKDJ2IHjydy=> M1v2d|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzM{mzNFA1Lz5{MUO5N|AxPDxxYU6=
NCI-H460 MkfaR5l1d3SxeHnjbZR6KGG|c3H5 NGXVZXhEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBPS0lvSES2NEBk\WyuczDh[pRmeiCxdnXycolocHRiaX7jeYJifGmxbjDifUBOXFRiYYPzZZktKEmFNUCgQUAyOi5|IN88UU4> MlXFQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF7NEK3OlUoRjJzOUSyO|Y2RC:jPh?=
RAW264.7 NYTRfmJpSW62aXnu[oxidW2jdH;yfUBie3OjeR?= MnPYNlQhcHK| Ml;FRY51cWmwZnzhcY1ifG:{eTDhZ5Rqfmm2eTDpckBud3W|ZTDSRXczPjRwNzDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKEySUz3pcoR2[2WmIF7PJJBzd2S3Y4Tpc44h[W[2ZYKgNlQhcHK|IHL5JGdzcWW|czDy[YFo\W62IH3leIhw\CxiSVO1NEA:KDFizszNMi=> NFLPOXc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUm3PFY4Pid-MkG5O|g3PzZ:L3G+
RAW264.7 NE[wOHlCdnSraX7mcIFudWG2b4L5JIF{e2G7 MXeyOEBpenN? MWDBcpRqcW6obHHtcYF1d3K7IHHjeIl3cXS7IHnuJI1wfXOnIGLBW|I3PC55IHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4YhVFCVLXnu[JVk\WRibnn0dolkKG:6aXTlJJBzd2S3Y4Tpc44h[W[2ZYKgNlQhcHK|IHL5JIdzcWW|czDhd5NigSxiSVO1NEA:KDFizszNMi=> MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjB{NECzN{c,OjJyMkSwN|M9N2F-
RAW264.7 M3P1eWZ2dmO2aX;uJIF{e2G7 NXvk[YpoOThiaILz NF7OfmJKdmirYnn0bY9vKG:oIFzQV{1{fGmvdXzheIVlKE6Ia3HwdIFDKGGldHn2ZZRqd25idILhcpNn\WO2ZXSgbY4hdW:3c3WgVmFYOjZ2LkegZ4VtdHNiYX\0[ZIhOThiaILzJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygTWM2OCB;IECuNkDPxE1w NF\WNYU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkewOVAzOCd-MkK3NFUxOjB:L3G+
spleen adherent cells MWDBcpRq[XK2aILpeIlkKGG|c3H5 MVKyNFAhfWd? MnLZRY51cWG{dHjybZRq[yCnZn\lZ5QhcW5iTHX3bZMhemG2IHHkbpV3[W62LXnu[JVk\WRiYYL0bJJqfGm|IH3v[IVtKHOybHXlckBi\GincnXueEBk\WyuczDy[ZN1cW23bHH0[YQhf2m2aDDzc45q[2G2ZXSgUZRjKHCxc4SgbZNwdGG2aX;uJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDDR3IzKGW6cILld5Nqd25iYYSgNlAxKHWpLDDpdEB{fGG{dHnu[{Bnem:vIHHyeIhzcXSrczDvcpNmfCCjbnSgZ49vfGmwdXXkJJVvcW62ZYLyeZB1\WRidX70bYw> NEK2Wo09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mki1OFE6Oyd-MkK4OVQyQTN:L3G+
spleen adherent cells M4\mTmFvfGmjcoTodol1cWNiYYPzZZk> NGPrPGQzODBidXe= MoDNRY51cWG{dHjybZRq[yCnZn\lZ5QhcW5iTHX3bZMhemG2IHHkbpV3[W62LXnu[JVk\WRiYYL0bJJqfGm|IH3v[IVtKHOybHXlckBi\GincnXueEBk\WyuczDy[ZN1cW23bHH0[YQhf2m2aDDzc45q[2G2ZXSgUZRjKHCxc4SgbZNwdGG2aX;uJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDHVm8wU0NicILv[JVkfGmxbjDheEAzODBidXesJIlxKHO2YYL0bY5oKG[{b32gZZJ1cHKrdHnzJI9ve2W2IHHu[EBkd262aX71[YQhfW6rboTldpJ2eHSnZDD1cpRq MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjh3NEG5N{c,OjJ6NUSxPVM9N2F-
spleen adherent cells MlXvRY51cWG{dHjybZRq[yCjc4PhfS=> NEe5UIgzODBidXe= NH;JSnZCdnSrYYL0bJJqfGmlIHXm[oVkfCCrbjDM[ZdqeyC{YYSgZYRrfX[jboStbY5lfWOnZDDhdpRpemm2aYOgcY9l\Wxic4Ds[YVvKGGmaHXy[Y51KGOnbHzzJJJme3SrbYXsZZRm\CC5aYToJJNwdmmlYYTl[EBOfGJicH;zeEBqe2:uYYTpc44h[XO|ZYPz[YQh[XNicnXkeYN1cW:wIHnuJG1EWDFicILv[JVkfGmxbjDheEAzODBidXesJIlxKHO2YYL0bY5oKG[{b32gZZJ1cHKrdHnzJI9ve2W2IHHu[EBkd262aX71[YQhfW6rboTldpJ2eHSnZDD1cpRqdA>? MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjh3NEG5N{c,OjJ6NUSxPVM9N2F-
spleen adherent cells NF7YWYlCdnSrYYL0bJJqfGmlIHHzd4F6 NWfZUYRnOjByIIXn MYnBcpRq[XK2aILpeIlkKGWoZnXjeEBqdiCOZYfpd{Bz[XRiYXTqeZZidnRvaX7keYNm\CCjcoTodol1cXNibX;k[Ywhe3CuZXXuJIFlcGW{ZX70JINmdGy|IILld5RqdXWuYYTl[EB4cXSqIIPvcolk[XSnZDDNeIIheG:|dDDpd49t[XSrb36gZZN{\XO|ZXSgZZMhemWmdXP0bY9vKGmwIGLBUnRGWyCycn;keYN1cW:wIHH0JFIxOCC3ZzygbZAhe3SjcoTpcoch\nKxbTDhdpRpemm2aYOgc45{\XRiYX7kJINwdnSrboXl[EB2dmmwdHXydpVxfGWmIIXueIk> NGfU[GU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mki1OFE6Oyd-MkK4OVQyQTN:L3G+
spleen adherent cells NEK3VXdCdnSrYYL0bJJqfGmlIHHzd4F6 NVv5WnZLOjByIIXn NEOyOVVCdnSrYYL0bJJqfGmlIHXm[oVkfCCrbjDM[ZdqeyC{YYSgZYRrfX[jboStbY5lfWOnZDDhdpRpemm2aYOgcY9l\Wxic4Ds[YVvKGGmaHXy[Y51KGOnbHzzJJJme3SrbYXsZZRm\CC5aYToJJNwdmmlYYTl[EBOfGJicH;zeEBqe2:uYYTpc44h[XO|ZYPz[YQh[XNicnXkeYN1cW:wIHnuJHRPTmGucHjhJJBzd2S3Y4Tpc44h[XRiMkCwJJVoNCCrcDDzeIFzfGmwZzDmdo9uKGG{dHjybZRqeyCxboPleEBidmRiY3;ueIlvfWWmIIXubY51\XK{dYD0[YQhfW5? NW\T[JVFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK4OVQyQTNpPkKyPFU1OTl|PD;hQi=>
spleen adherent cells MYfBcpRq[XK2aILpeIlkKGG|c3H5 M3;nSFIxOCC3Zx?= M1HjOGFvfGmjcoTodol1cWNiZX\m[YN1KGmwIFzle4l{KHKjdDDh[Ip2fmGwdD3pcoR2[2WmIHHyeIhzcXSrczDtc4RmdCC|cHzl[Y4h[WSqZYLlcpQh[2WubIOgdoV{fGmvdXzheIVlKHerdHigd49vcWOjdHXkJG11[iCyb4P0JIl{d2yjdHnvckBie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gR2NTOyCneIDy[ZN{cW:wIHH0JFIxOCC3ZzygbZAhe3SjcoTpcoch\nKxbTDhdpRpemm2aYOgc45{\XRiYX7kJINwdnSrboXl[EB2dmmwdHXydpVxfGWmIIXueIlt NYnKNXp6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK4OVQyQTNpPkKyPFU1OTl|PD;hQi=>
spleen adherent cells MkDmRY51cWG{dHjybZRq[yCjc4PhfS=> MYWyNFAhfWd? Ml;VRY51cWG{dHjybZRq[yCnZn\lZ5QhcW5iTHX3bZMhemG2IHHkbpV3[W62LXnu[JVk\WRiYYL0bJJqfGm|IH3v[IVtKHOybHXlckBi\GincnXueEBk\WyuczDy[ZN1cW23bHH0[YQhf2m2aDDzc45q[2G2ZXSgUZRjKHCxc4SgbZNwdGG2aX;uJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDDR3I3KGW6cILld5Nqd25iYYSgNlAxKHWpLDDpdEB{fGG{dHnu[{Bnem:vIHHyeIhzcXSrczDvcpNmfCCjbnSgZ49vfGmwdXXkJJVvcW62ZYLyeZB1\WRidX70bYw> NVTqUphWRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK4OVQyQTNpPkKyPFU1OTl|PD;hQi=>
spleen adherent cells NHvEe2lCdnSrYYL0bJJqfGmlIHHzd4F6 NELwXGIzODBidXe= Ml;0RY51cWG{dHjybZRq[yCnZn\lZ5QhcW5iTHX3bZMhemG2IHHkbpV3[W62LXnu[JVk\WRiYYL0bJJqfGm|IH3v[IVtKHOybHXlckBi\GincnXueEBk\WyuczDy[ZN1cW23bHH0[YQhf2m2aDDzc45q[2G2ZXSgUZRjKHCxc4SgbZNwdGG2aX;uJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDDXGNTOSCneIDy[ZN{cW:wIHH0JFIxOCC3ZzygbZAhe3SjcoTpcoch\nKxbTDhdpRpemm2aYOgc45{\XRiYX7kJINwdnSrboXl[EB2dmmwdHXydpVxfGWmIIXueIlt M3v0eFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{OEW0NVk{Lz5{Mki1OFE6OzxxYU6=
spleen adherent cells MYrBcpRq[XK2aILpeIlkKGG|c3H5 NX;vc|lPOjByIIXn M1m4T2FvfGmjcoTodol1cWNiZX\m[YN1KGmwIFzle4l{KHKjdDDh[Ip2fmGwdD3pcoR2[2WmIHHyeIhzcXSrczDtc4RmdCC|cHzl[Y4h[WSqZYLlcpQh[2WubIOgdoV{fGmvdXzheIVlKHerdHigd49vcWOjdHXkJG11[iCyb4P0JIl{d2yjdHnvckBie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gR3hEWjJiZYjwdoV{e2mxbjDheEAzODBidXesJIlxKHO2YYL0bY5oKG[{b32gZZJ1cHKrdHnzJI9ve2W2IHHu[EBkd262aX71[YQhfW6rboTldpJ2eHSnZDD1cpRqdA>? M3niTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{OEW0NVk{Lz5{Mki1OFE6OzxxYU6=
spleen adherent cells M37EeWFvfGmjcoTodol1cWNiYYPzZZk> MoDhNlAxKHWp MmHoRY51cWG{dHjybZRq[yCnZn\lZ5QhcW5iTHX3bZMhemG2IHHkbpV3[W62LXnu[JVk\WRiYYL0bJJqfGm|IH3v[IVtKHOybHXlckBi\GincnXueEBk\WyuczDy[ZN1cW23bHH0[YQhf2m2aDDzc45q[2G2ZXSgUZRjKHCxc4SgbZNwdGG2aX;uJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDDXGNTPCCneIDy[ZN{cW:wIHH0JFIxOCC3ZzygbZAhe3SjcoTpcoch\nKxbTDhdpRpemm2aYOgc45{\XRiYX7kJINwdnSrboXl[EB2dmmwdHXydpVxfGWmIIXueIlt NGm2NHE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mki1OFE6Oyd-MkK4OVQyQTN:L3G+
spleen adherent cells Mni4SpVv[3Srb36gZZN{[Xl? Ml7NNlAxKHWp MV;JcoNz\WG|ZTDpckBES1JzIHX4dJJme3Orb36gbY4hVGW5aYOgdoF1KGGmaoX2ZY51NWmwZIXj[YQh[XK2aILpeIl{KG2xZHXsJJNxdGWnbjDh[IhmemWwdDDj[YxteyC{ZYP0bY12dGG2ZXSge4l1cCC|b37pZ4F1\WRiTYTiJJBwe3RiaYPvcIF1cW:wIHH0JFIxOCC3ZzygbZAhe3SjcoTpcoch\nKxbTDhdpRpemm2aYOgc45{\XRiYX7kJINwdnSrboXl[EB2dmmwdHXydpVxfGWmIIXueIltKHO2dXT5JIVv\CCkeTDxVGNTKHKnbHH0bZZmKGKjc3XsbY4> NFnV[3c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mki1OFE6Oyd-MkK4OVQyQTN:L3G+
spleen adherent cells NYnPNpdkSW62aXHyeIhzcXSrYzDhd5NigQ>? NF7McpgzODBidXe= M4LhUGFvfGmjcoTodol1cWNiZX\m[YN1KGmwIFzle4l{KHKjdDDh[Ip2fmGwdD3pcoR2[2WmIHHyeIhzcXSrczDtc4RmdCC|cHzl[Y4h[WSqZYLlcpQh[2WubIOgdoV{fGmvdXzheIVlKHerdHigd49vcWOjdHXkJG11[iCyb4P0JIl{d2yjdHnvckBie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gTWwuOWKndHGgdJJw\HWldHnvckBifCB{MECgeYctKGmyIIP0ZZJ1cW6pIH\yc40h[XK2aILpeIl{KG:wc3X0JIFv\CClb370bY52\WRidX7pcpRmenK3cITl[EB2dg>? NHLHXGw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mki1OFE6Oyd-MkK4OVQyQTN:L3G+
spleen adherent cells MVnBcpRq[XK2aILpeIlkKGG|c3H5 M3iwblIxOCC3Zx?= M4KyemFvfGmjcoTodol1cWNiZX\m[YN1KGmwIFzle4l{KHKjdDDh[Ip2fmGwdD3pcoR2[2WmIHHyeIhzcXSrczDtc4RmdCC|cHzl[Y4h[WSqZYLlcpQh[2WubIOgdoV{fGmvdXzheIVlKHerdHigd49vcWOjdHXkJG11[iCyb4P0JIl{d2yjdHnvckBie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gR2NTPSCneIDy[ZN{cW:wIHH0JFIxOCC3ZzygbZAhe3SjcoTpcoch\nKxbTDhdpRpemm2aYOgc45{\XRiYX7kJINwdnSrboXl[EB2dmmwdHXydpVxfGWmIIXueIlt NHX4bYE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mki1OFE6Oyd-MkK4OVQyQTN:L3G+
spleen adherent cells MUTGeY5kfGmxbjDhd5NigQ>? NFe1VIUzPCCqcoO= M4LacWlv[3KnYYPlJIlvKEOFUkGgdJJwfGWrbjDzeZJn[WOnIHX4dJJme3Orb36gbY4he2:waXPheIVlKE22Yj3zeIlufWyjdHXkJJNxdGWnbjDh[IhmemWwdDDj[YxteyCrc3;sZZRm\CCocn;tJGxmf2m|IILheEBi\Gq3dnHueE1qdmS3Y3XkJIFzfGi{aYTpd{Bud2SnbDDwdoUucW6ldXLheIVlKHerdHigNE4yKHSxIECuN{B2VSClb33wc5Vv\CCkZX\vdoUhe3SrbYXsZZRqd25id3n0bEB{d26rY3H0[YQhVXSkIH\vdkAzPCCqcoOgZpkh\myxdzDjfZRwdQ>? NIiz[ow9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mki1OFE6Oyd-MkK4OVQyQTN:L3G+
RAW264.7 NETVOWxCdnSraX7mcIFudWG2b4L5JIF{e2G7 MUKyOEBpenN? MYTBcpRqcW6obHHtcYF1d3K7IHHjeIl3cXS7IHnuJI1wfXOnIGLBW|I3PC55IHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4YhVFCVLXnu[JVk\WRiTl:gdJJw\HWldHnvckBi\nSncjCyOEBpenNiYomgS5Jq\XO|IH3leIhw\CxiSVO1NEA:KDFizszNMi=> MoTmQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNzMke4PFYoRjJ|MUK3PFg3RC:jPh?=
RAW264.7 MX;BcpRqcW6obHHtcYF1d3K7IHHzd4F6 NXXTeGZTOjRiaILz Mm[1RY51cWmwZnzhcY1ifG:{eTDhZ5Rqfmm2eTDpckBud3W|ZTDSRXczPjRwNzDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKEySUz3pcoR2[2WmIGTOSoFteGijIIDyc4R2[3Srb36gbY5kfWKjdHXkJIZweiB{NDDodpMh[nliRVzJV2EtKEmFNUCgQUAxNjhizszNMi=> NHP2TJc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{KzOFQxPyd-MkOyN|Q1ODd:L3G+
RAW264.7 MWDBcpRqcW6obHHtcYF1d3K7IHHzd4F6 M3HT[VI1KGi{cx?= MlXxRY51cWmwZnzhcY1ifG:{eTDhZ5Rqfmm2eTDpckBud3W|ZTDSRXczPjRwNzDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKEySUz3pcoR2[2WmIH7peJJq[yCxeHnk[UBo\W6ncnH0bY9vKGmwY4XiZZRm\CCob4KgNlQhcHK|LDDJR|UxKD1iMTFOwG0v NF;hU289[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{KzOFQxPyd-MkOyN|Q1ODd:L3G+
RAW264.7 M1zyU2FvfGmrbn\sZY1u[XSxcomgZZN{[Xl? MknYRY51cS2rbn\sZY1u[XSxcomgZYN1cX[rdImgbY4hdW:3c3WgVmFYOjZ2LkegZ4VtdHNiYYPz[ZN{\WRiYYOgbY5pcWKrdHnvckBw\iCOUGOtbY5lfWOnZDDubZRzcWNib4jp[IUheHKxZIXjeIlwdiCkeTDHdolme3NicnXhZ5Rqd25iYnHz[YQhdWW2aH;kMEBKSzVyIE2gNUDPxE1w MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTZ|N{O2N{c,OjV4M{ezOlM9N2F-
MCF7 MY\DfZRwfG:6aXPpeJkh[XO|YYm= MVW3NkBpenN? M1u1XWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJG1ETjdiY3XscJMh[XO|ZYPz[YQh[XNiZ4Lve5RpKGmwaHnibZRqd25iYX\0[ZIhPzJiaILzJIJ6KE2WUz;QUXMh[XO|YYmsJGlEPTBiPTCwMlE2OyEQvF2u Ml\5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV5NU[yPVkoRjJ3N{W2Nlk6RC:jPh?=
MCF7 MlLQSpVv[3Srb36gZZN{[Xl? NUTQSGtvOjRiaILz M1[zbmlvcGmkaYTpc44hd2ZiSGPQPVAhcW5iaIXtZY4hVUOINzDj[YxteyCjc4Pld5Nm\CCjczDwRYt1KGSnZ4Lh[IF1cW:wIHH0JFUhfGmvZYOgTWM2OCCjZoTldkAzPCCqcoOgZpkhX2W|dHXyckBjdG:2IHHuZYx6e2m| MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTd3NkK5PUc,OjV5NU[yPVk9N2F-
MCF7 M3PhZmZ2dmO2aX;uJIF{e2G7 MYeyOEBpenN? MXTJcohq[mm2aX;uJI9nKEiVUEmwJIlvKGi3bXHuJG1ETjdiY3XscJMh[XO|ZYPz[YQh[XNiSHXyNkBl\We{YXTheIlwdiCjdDC1JJRqdWW|IFnDOVAh[W[2ZYKgNlQhcHK|IHL5JHdme3Sncn6gZoxwfCCjbnHsfZNqew>? M1LkdFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3N{W2Nlk6Lz5{NUe1OlI6QTxxYU6=
MCF7 NIf6endHfW6ldHnvckBie3OjeR?= NXPDPIJxOjRiaILz M4Hhd2lvcGmkaYTpc44hd2ZiSGPQPVAhcW5iaIXtZY4hVUOINzDj[YxteyCjc4Pld5Nm\CCjczDD[Is3KGSnZ4Lh[IF1cW:wIHH0JFUhfGmvZYOgTWM2OCCjZoTldkAzPCCqcoOgZpkhX2W|dHXyckBjdG:2IHHuZYx6e2m| Mle4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV5NU[yPVkoRjJ3N{W2Nlk6RC:jPh?=
MCF7 MV;GeY5kfGmxbjDhd5NigQ>? NFH5W4wzPCCqcoO= M{DkNWlvcGmkaYTpc44hd2ZiSGPQPVAhcW5iaIXtZY4hVUOINzDj[YxteyCjc4Pld5Nm\CCjczDSZYYh\GWpcnHkZZRqd25iYYSgOUB1cW2nczDJR|UxKGGodHXyJFI1KGi{czDifUBY\XO2ZYLuJIJtd3RiYX7hcJl{cXN? NYLxb2NnRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW3OVYzQTlpPkK1O|U3Ojl7PD;hQi=>
MCF7 NF;1cFJHfW6ldHnvckBie3OjeR?= NUXaeYJ4OjRiaILz M3;yVGNp[W6pZTDpckBE\GN|NzDlfJBz\XO|aX;uJIlvKGi3bXHuJG1ETjdiY3XscJMh[XRiNTD0bY1meyCLQ{WwJIFnfGW{IEK0JIhzeyCkeTDX[ZN1\XKwIHLsc5Qh[W6jbInzbZM> MnnuQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV5NU[yPVkoRjJ3N{W2Nlk6RC:jPh?=
MCF7 MVLGeY5kfGmxbjDhd5NigQ>? MYWyOEBpenN? NYKx[XJxS2ijbnflJIlvKHB{MzDlfJBz\XO|aX;uJIlvKGi3bXHuJG1ETjdiY3XscJMh[XRiNTD0bY1meyCLQ{WwJIFnfGW{IEK0JIhzeyCkeTDX[ZN1\XKwIHLsc5Qh[W6jbInzbZM> MoHnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV5NU[yPVkoRjJ3N{W2Nlk6RC:jPh?=
MCF7 NHy0cVBHfW6ldHnvckBie3OjeR?= M4L2U|I1KGi{cx?= Ml3YTY5pcWKrdHnvckBw\iCKU2C5NEBqdiCqdX3hckBOS0Z5IHPlcIx{KGG|c3Xzd4VlKGG|IHTpd5J2eHSrb36gc4YhcW62ZYLhZ5Rqd25id3n0bEBE\GN|NzDheEA2KHSrbXXzJGlEPTBiYX\0[ZIhOjRiaILzJIJ6KGOxLXntcZVvd3C{ZXPpdIl1[XSrb36gZZN{[Xl? NVnjNpE1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW3OVYzQTlpPkK1O|U3Ojl7PD;hQi=>
MCF7 M3PKcWZ2dmO2aX;uJIF{e2G7 NHjWc5UzPCCqcoO= M1\iO2lvcGmkaYTpc44hd2ZiSGPQPVAhcW5iaIXtZY4hVUOINzDj[YxteyCjc4Pld5Nm\CCjczDkbZNzfXC2aX;uJI9nKGmwdHXyZYN1cW:wIIfpeIgheDJ|IHH0JFUhfGmvZYOgTWM2OCCjZoTldkAzPCCqcoOgZpkh[29vaX3teY5weHKnY3nwbZRifGmxbjDhd5NigQ>? NWHCdmlWRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW3OVYzQTlpPkK1O|U3Ojl7PD;hQi=>
SGC7901 M3v5TWFvfGmlYX7j[ZIh[XO|YYm= NVvONZNqPDhiaILz NVPXPYFuSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJHNISzd7MEGgZ4VtdHNiYYPz[ZN{\WRiYYOgZ4VtdCC|dYL2bZZidCCjZoTldkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOC5zNTFOwG0v M3\2RVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OEGyPVY3Lz5{NUixNlk3PjxxYU6=
SMMC7721 Mn;WRY51cWOjbnPldkBie3OjeR?= MVq0PEBpenN? NGezSYNCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gV21OSzd5MkGgZ4VtdHNiYYPz[ZN{\WRiYYOgZ4VtdCC|dYL2bZZidCCjZoTldkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOC53ODFOwG0v M2LvUVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OEGyPVY3Lz5{NUixNlk3PjxxYU6=
MGC803 NYTQZmRSSW62aXPhcoNmeiCjc4PhfS=> MWi0PEBpenN? MkjKRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3HR|gxOyClZXzsd{Bie3Onc4Pl[EBieyClZXzsJJN2en[rdnHsJIFnfGW{IES4JIhzeyCkeTDNWHQh[XO|YYmsJGlEPTBiPTCxMlU2KM7:TT6= MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPThzMkm2Okc,OjV6MUK5OlY9N2F-
HepG2 Mm\1RY51cWOjbnPldkBie3OjeR?= NIDqSHc1QCCqcoO= Mmm4RY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjldGczKGOnbHzzJIF{e2W|c3XkJIF{KGOnbHygd5Vzfmm4YXygZYZ1\XJiNEigbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IESuNFEh|ryPLh?= MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPThzMkm2Okc,OjV6MUK5OlY9N2F-
A549 MlTRRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? M2fUNlQ5KGi{cx?= MlPBRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDwZYNtcXSjeHXsMZJme2m|dHHueEBpfW2jbjDBOVQ6KGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDj[YxtKH[rYXLpcIl1gSCjZoTldkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOi5yMTFOwG0v NF;qXYk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{[0O|M3QSd-Mke2OFc{Pjl:L3G+
A549 NHvFdIJCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NGHpU3Q1QCCqcoO= NUnnUWViSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDBOVQ6KGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDj[YxtKH[rYXLpcIl1gSCjZoTldkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOi5yMjFOwG0v Mn3IQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjd4NEezOlkoRjJ5NkS3N|Y6RC:jPh?=
MCF7 MmLiRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? NID1UJA1QCCqcoO= MYPBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKE2FRkegZ4VtdHNiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJIlvKGOnbHygeoli[mmuaYT5JIFnfGW{IES4JIhzeyCkeTDNWHQh[XO|YYmsJGlEPTBiPTCyMlE{KM7:TT6= NGDyNWs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{[0O|M3QSd-Mke2OFc{Pjl:L3G+
PANC1 M2Dhc2FvfGmycn;sbYZmemG2aY\lJIF{e2G7 NHXucZg1QCCqcoO= NHLscVFCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGDBUmMyKGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDj[YxtKH[rYXLpcIl1gSCjZoTldkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOi52ODFOwG0v NX3x[nd5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMke2OFc{PjlpPkK3OlQ4OzZ7PD;hQi=>
LNCAP M3jVW2Z2dmO2aX;uJIF{e2G7 MnO5OUB2VQ>? M2\ObFI1KGi{cx?= MX;BcpRi\2:waYP0JIFkfGm4aYT5JIF1KEGUIHnuJIh2dWGwIFzOR2FRKGOnbHzzJIF{e2W|c3XkJIF{KHO3cIDy[ZN{cW:wIH;mJGRJXC2rbnT1Z4VlKHKnY3XweI9zKHS{YX7zZ5JqeHSrb37hcEBi[3Srdnn0fUBifCB3IIXNJIFnfGW{IEK0JIhzeyCkeTDkeYFtKGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeR?= MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzl7NEezNUc,Ojd7OUS3N|E9N2F-
A549 NFTvbVFIem:5dHigbY5pcWKrdHnvckBie3OjeR?= NFvCXIY3KGSjeYO= NWD4cGJQT3Kxd4ToJIlvcGmkaYTpc44hd2ZiaIXtZY4hSTV2OTDj[YxteyCvZXHzeZJm\CCndnXyfUAzKGi{czDveoVzKDZiZHH5d{BjgSCuaY\lJINmdGxiaX3h[4lv\yCkYYPl[EBu\XSqb3SsJGlEPTBiPTCwMlY6KM7:TT6= M4LRNVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6NkKxPVQ{Lz5{OE[yNVk1OzxxYU6=
HEK293 MXPGeY5kfGmxbjDhd5NigQ>? NHPhdGwyOCC3TR?= NGDaNHkzOCCvaX7z M3OzdmlvcGmkaYTpc44hd2ZiR3HsdIhidyCrboTldoFkfGmxbjD3bZRpKEeIUD3meZNm\CCUR2OxO{ApfW6tbn;3ckBwemmpaX6pJIRmdHSjTjDteZRidnRiZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBTT1NzNzDk[Yx1[U5ibYX0ZY51KGyxY3HsbZpifGmxbjDheEBkgXSxcHzhd40h[XRiMUCgeW0hfXBidH:gNlAhdWmwczDifUBkd26ob3PhcEBucWO{b4Pjc5Bq[yCjbnHsfZNqew>? MnXVQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh4MkG5OFMoRjJ6NkKxPVQ{RC:jPh?=
HEK293 M{nieWZ2dmO2aX;uJIF{e2G7 MoTNNVAxKHWP MYC1JI1qdnN? NU\PRXZOUW6qaXLpeIlwdiCxZjDHZYxxcGFyIHnueIVz[WO2aX;uJJdqfGhiR1\QMYZ2e2WmIGLHV|E4KCi3bnvuc5dvKG:{aXfpckkh\GWudHHOJI12fGGwdDDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKFKJU{G3JIRmdHSjTjDteZRidnRibH;jZYxqgmG2aX;uJIF1KGO7dH;wcIF{dSCjdDCxNFAhfU1idYCgeI8hPSCvaX7zJIJ6KGOxbn\vZ4FtKG2rY4Lvd4NweGmlIHHuZYx6e2m| MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDZ{MUm0N{c,Ojh4MkG5OFM9N2F-
HEK293 M1Hyc2Z2dmO2aX;uJIF{e2G7 M{[yOlExKHWP NWLpbmFDPSCvaX7z M{fTVGlvcGmkaYTpc44hd2ZiR3HsdIhidyCrboTldoFkfGmxbjD3bZRpKEeIUD3meZNm\CCUR2OxO{ApfW6tbn;3ckBwemmpaX6pJIRmdHSjTjDteZRidnRiZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBTT1NzNzDk[Yx1[U5ibYX0ZY51KGyxY3HsbZpifGmxbjDheEBkgXSxcHzhd40h[XRiMUCgeW0hfXBidH:gOUBucW6|IHL5JINwdm[xY3HsJI1q[3Kxc3PvdIlkKGGwYXz5d4l{ NFPQNXY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OE[yNVk1Oyd-Mki2NlE6PDN:L3G+
MIAPaCa2 MkDqRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? M{HsfFczKGi{cx?= NW\n[2x7SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNTWFR[UOjMjDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOC52NjFOwG0v NF74Ulg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OE[4PFI5OSd-Mki2PFgzQDF:L3G+
SKBR3 NXfjXldbSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= MYO3NkBpenN? M2TlZWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iU1vCVlMh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IECuO|Ih|ryPLh?= NE\zdpk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OE[4PFI5OSd-Mki2PFgzQDF:L3G+
SKOV3 NUPDXYs{SW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= M4fOdlczKGi{cx?= M13XN2FvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iU1vPWlMh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IEGuNVYh|ryPLh?= MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDZ6OEK4NUc,Ojh4OEiyPFE9N2F-
MDA-MB-231 NHPIXotCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MVi3NkBpenN? NVvMRlN6SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNSGEuVUJvMkOxJINmdGy|IHHmeIVzKDd{IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSBzLkOyJO69VS5? NWe4Onh7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki2PFgzQDFpPkK4Olg5OjhzPD;hQi=>
A549 NW\tOnRNSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NW\0cXl7PzJiaILz NXO1e|Q2SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDBOVQ6KGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDNWHQh[XO|YYmsJGlEPTBiPTCxMlU3KM7:TT6= MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDZ6OEK4NUc,Ojh4OEiyPFE9N2F-
BJ NV3qdWpnS3m2b4TvfIlkcXS7IHHzd4F6 M3LTbVczKGi{cx?= NXHadWQ1S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hSkpiY3XscJMh[XO|ZYPz[YQh[XNicnXkeYN1cW:wIHnuJINmdGxidnnhZoltcXS7IHHmeIVzKDd{IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSB{Lke0JO69VS5? MWC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDZ6OEK4NUc,Ojh4OEiyPFE9N2F-
NCI-H460 M1fu[WZ2dmO2aX;uJIF{e2G7 MlziNUB2VQ>? M1LqXFEzKGi{cx?= NVXNeXROSWO2aY\heIlwdiCxZjDIV2YyKGmwIHj1cYFvKE6FST3IOFYxKGOnbHzzJIF{e2W|c3XkJIF{KHWycnXneYxifGmxbjDv[kBJW1B{NTDwdo91\WmwIHzleoVteyCjdDCxJJVOKGGodHXyJFEzKGi{czDifUBY\XO2ZYLuJIJtd3RiYX7hcJl{cXN? NIPvcZU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEezO|kyPid-Mki3N|c6OTZ:L3G+
NCI-H460 NI\IdZBHfW6ldHnvckBie3OjeR?= M3fS[FEhfU1? MlnJNVIhcHK| MYLBZ5RqfmG2aX;uJI9nKEiVRkGgbY4hcHWvYX6gUmNKNUh2NkCgZ4VtdHNiYYPz[ZN{\WRiYYOgeZBz\We3bHH0bY9vKG:oIFjTVFcxKHC{b4TlbY4hdGW4ZXzzJIF1KDFidV2gZYZ1\XJiMUKgbJJ{KGK7IGfld5Rmem5iYnzveEBidmGueYPpdy=> MknPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh5M{e5NVYoRjJ6N{O3PVE3RC:jPh?=
NCI-H1299 M1q2S2N6fG:2b4jpZ4l1gSCjc4PhfS=> NILsPJNEgXSxdH;4bYNqfHliaX6gbJVu[W5iTlPJMWgyOjl7IHPlcIx{KGG|c3Xzd4VlKGG|IILl[JVkfGmxbjDpckBk\WyuII\pZYJqdGm2eTygTWM2OCB;IEGg{txONg>? M3;ZfFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6N{W0OFcxLz5{OEe1OFQ4ODxxYU6=
BCP-ALL Ml3zR5l1d3SxeHnjbZR6KGG|c3H5 NILVdGlEgXSxdH;4bYNqfHliaX6gbJVu[W5iQlPQMWFNVCClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gZ4VtdCC4aXHibYxqfHluIFnDOVAhRSBzIN88UU4> MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDd3NES3NEc,Ojh5NUS0O|A9N2F-
T-ALL MULDfZRwfG:6aXPpeJkh[XO|YYm= NUXyZoNYS3m2b4TvfIlkcXS7IHnuJIh2dWGwIGStRWxNKGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDj[YxtKH[rYXLpcIl1gSxiSVO1NEA:KDFizszNMi=> M{TTUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6N{W0OFcxLz5{OEe1OFQ4ODxxYU6=
Daudi MmX6R5l1d3SxeHnjbZR6KGG|c3H5 MVnDfZRwfG:6aXPpeJkhcW5iaIXtZY4hTGG3ZHmgZ4VtdHNiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJIlvKGOnbHygeoli[mmuaYT5MEBKSzVyIE2gNUDPxE1w NXXSRpg3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki3OVQ1PzBpPkK4O|U1PDdyPD;hQi=>
HL60 NH\D[m1EgXSxdH;4bYNqfHliYYPzZZk> MoDVR5l1d3SxeHnjbZR6KGmwIHj1cYFvKEiONkCgZ4VtdHNiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJIlvKGOnbHygeoli[mmuaYT5MEBKSzVyIE2gNUDPxE1w NXjSOWdsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki3OVQ1PzBpPkK4O|U1PDdyPD;hQi=>
TC32 MnvGdWhVWyCjc4PhfS=> NHjQTlhyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiVFOzNkBk\Wyucx?= MlrOQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
DAOY M1TiNZFJXFNiYYPzZZk> NILXPVhyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiRFHPXUBk\Wyucx?= Mnv5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
SJ-GBM2 NH76Z|ZyUFSVIHHzd4F6 MX3xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0pvR1LNNkBk\Wyucx?= M{nKcVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
A673 MVHxTHRUKGG|c3H5 NUjiXItmeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IFG2O|Mh[2WubIO= MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
SK-N-MC M2fvUJFJXFNiYYPzZZk> MUDxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0tvTj3NR{Bk\Wyucx?= NUDCdFUyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
BT-37 NVjGVlhieUiWUzDhd5NigQ>? NWrvTYJ{eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IFLUMVM4KGOnbHzz NHP1SoU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
NB-EBc1 MlPidWhVWyCjc4PhfS=> NFK0dXNyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiTlKtSWJkOSClZXzsdy=> MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
Saos-2 MmC0dWhVWyCjc4PhfS=> NFLW[4FyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiU3Hvd{0zKGOnbHzz NHnPd4s9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
SK-N-SH NY\xdlB1eUiWUzDhd5NigQ>? NXK0XmMzeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGPLMW4uW0hiY3XscJM> NHi0dm09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
NB1643 M{XkWZFJXFNiYYPzZZk> Mn6wdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKE6EMU[0N{Bk\Wyucx?= M3TSOVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
LAN-5 M3;R[ZFJXFNiYYPzZZk> NGXyVolyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiTFHOMVUh[2WubIO= NH\XXmY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
BT-12 MYTxTHRUKGG|c3H5 MnvkdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKEKWLUGyJINmdGy| NYXLe5ZtRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
Rh18 MYTxTHRUKGG|c3H5 M{HuOpFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCUaEG4JINmdGy| MWC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
OHS-50 MnfsdWhVWyCjc4PhfS=> NYW3R296eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IF;IV{02OCClZXzsdy=> NVjKNmFsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
RD NUS2bW9xeUiWUzDhd5NigQ>? NXHyeoJ7eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGLEJINmdGy| M2HI[|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
MG 63 (6-TG R) M4r2bJFJXFNiYYPzZZk> M2XIUJFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCPRzC2N{ApPi2WRzDSLUBk\Wyucx?= M2LiOlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
Rh30 M4jJfZFJXFNiYYPzZZk> MW\xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhWmh|MDDj[Yxtew>? MXS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
Rh41 MX;xTHRUKGG|c3H5 NXrId2FDeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGLoOFEh[2WubIO= MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
NB1643 M1LsbpFJXFNiYYPzZZk> NELifFJyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCFb37mbZJu[XSxcomgd4Nz\WWwIH\vdkBPSjF4NEOgZ4VtdHN? M1G2TFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
A673 M{fDXJFJXFNiYYPzZZk> NFTzS4RyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCFb37mbZJu[XSxcomgd4Nz\WWwIH\vdkBCPjd|IHPlcIx{MQ>? MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
SK-N-MC NG\5NmFyUFSVIHHzd4F6 M1TUc5FJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KEOxbn\pdo1ifG:{eTDzZ5Jm\W5iZn;yJHNMNU5vTVOgZ4VtdHN? M{TTZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
BT-12 MnHLdWhVWyCjc4PhfS=> M3;ESZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KEOxbn\pdo1ifG:{eTDzZ5Jm\W5iZn;yJGJVNTF{IHPlcIx{ MmTkQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
LAN-5 M1fpUpFJXFNiYYPzZZk> M1HvbJFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KEOxbn\pdo1ifG:{eTDzZ5Jm\W5iZn;yJGxCVi13IHPlcIx{ NG\u[Y89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
DAOY M2\tO5FJXFNiYYPzZZk> MYPxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBEd26oaYLtZZRwenlic3Py[YVvKG[xcjDERW9[KGOnbHzz NYXEU3FNRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
NB-EBc1 MYTxTHRUKGG|c3H5 MkL5dWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohS2:wZnnycYF1d3K7IIPjdoVmdiCob4KgUmIuTUKlMTDj[Yxtew>? NEDT[4k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
SJ-GBM2 NX;LcFQ6eUiWUzDhd5NigQ>? Mki0dWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohS2:wZnnycYF1d3K7IIPjdoVmdiCob4KgV2ouT0KPMjDj[Yxtew>? MnHzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
BT-37 MlvmdWhVWyCjc4PhfS=> M1XENpFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KEOxbn\pdo1ifG:{eTDzZ5Jm\W5iZn;yJGJVNTN5IHPlcIx{ NEDWUmI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
TC32 M3jJNpFJXFNiYYPzZZk> MkSwdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohS2:wZnnycYF1d3K7IIPjdoVmdiCob4KgWGM{OiClZXzsdy=> M4C3SVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
MG 63 (6-TG R) MX7xTHRUKGG|c3H5 NGrjW5lyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCFb37mbZJu[XSxcomgd4Nz\WWwIH\vdkBOTyB4MzCoOk1VTyCUKTDj[Yxtew>? M1S0NFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
fibroblast cells M3m0NpFJXFNiYYPzZZk> MXjxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBEd26oaYLtZZRwenlic3Py[YVvKG[xcjDjc451em:uIFjoJJdqdGRidInw[UBncWK{b3LsZZN1KGOnbHzz Mn20QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
U-2 OS NX:0ZoVReUiWUzDhd5NigQ>? NF7VWoZyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCFb37mbZJu[XSxcomgd4Nz\WWwIH\vdkBWNTJiT2OgZ4VtdHN? M3O2Z|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
Rh41 NIPvU4RyUFSVIHHzd4F6 M{fq[ZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KEOxbn\pdo1ifG:{eTDzZ5Jm\W5iZn;yJHJpPDFiY3XscJM> MoHTQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
RD NXTyOWJueUiWUzDhd5NigQ>? NWXqRlZteUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiQ3;u[olzdWG2b4L5JJNkemWnbjDmc5IhWkRiY3XscJM> M2raTFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
Rh18 NVTxUlF4eUiWUzDhd5NigQ>? MnHGdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohS2:wZnnycYF1d3K7IIPjdoVmdiCob4KgVogyQCClZXzsdy=> M3jmWVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
Rh30 MYDxTHRUKGG|c3H5 M2XhdZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KEOxbn\pdo1ifG:{eTDzZ5Jm\W5iZn;yJHJpOzBiY3XscJM> MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
Saos-2 MYjxTHRUKGG|c3H5 Mly2dWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohS2:wZnnycYF1d3K7IIPjdoVmdiCob4KgV4Fwey1{IHPlcIx{ NIX2bWg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
OHS-50 NVXjcpRGeUiWUzDhd5NigQ>? MkHTdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohS2:wZnnycYF1d3K7IIPjdoVmdiCob4KgU2hUNTVyIHPlcIx{ M165e|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
SK-N-SH MUXxTHRUKGG|c3H5 NFLpfFlyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCFb37mbZJu[XSxcomgd4Nz\WWwIH\vdkBUUy2QLWPIJINmdGy| MUe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
HCT116 NH;xR4ZCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= Mm\6OFghcHK| MmnBRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCKQ2SxNVYh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IEWuNlYh|ryPLh?= MlzhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2OE[5OVQoRjJ7NEi2PVU1RC:jPh?=
HepG2 MVHBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? M{LRRVQ5KGi{cx?= MXXBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEincFeyJINmdGy|IHHmeIVzKDR6IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSB4LkG3JO69VS5? NV[xUpc6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0PFY6PTRpPkK5OFg3QTV2PD;hQi=>
A549 NYjKSJJISW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= MUS0PEBpenN? NGfwXHNCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFG1OFkh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IE[uOVkh|ryPLh?= MkXaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2OE[5OVQoRjJ7NEi2PVU1RC:jPh?=
MCF7 NUKyN3JISW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NEXlXI81QCCqcoO= NYXLT5M{SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNR2Y4KGOnbHzzJIFnfGW{IES4JIhzeyCkeTDNWHQh[XO|YYmsJGlEPTBiPTC2Mlg1KM7:TT6= MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR6Nkm1OEc,Ojl2OE[5OVQ9N2F-
HEK293 NHLsTIJEgXSxdH;4bYNqfHliYYPzZZk> MU\DfZRwfG:6aXPpeJkh[WejaX7zeEBJTUt{OUOgZ4VtdHNiKFPPMWFFTDqPQW:wNFcqQyCFQ{WwJIJ6KGOnbHygeoli[mmuaYT5JIF{e2G7IHnuJGROTU1iKEGwKUBHSlNrIH3l[IliKHW|aX7nJHREKHCuYYTld{wh[nliUnXzZZp2emmwIF[oOVYxNzV7MDmsJGNEPTBiPTCwMlg{PyEQvF2u MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyzNFE6QDJxJ{7DbGVOSkx:L3G+
Assay
Methods Test Index PMID
Western blot HIF-1α ; Akt / p-Akt / p-p70S6K ; PARP / p53 / p21 / cIAP1 / Bcl-xl / Bcl-2 ; IκBα / p-IKKα/β ; iNOS / COX-2 / Arg-1 ; Chk2 / p-Chk2 / Cyclin B1 / Cdc25c / p-Cdc25c 25383959 28388439 29040966 31053160
Immunofluorescence p21 / Nur77 28388439
Growth inhibition assay Cell viability 29040966
In vivo Celastrol (3 mg/kg) results in significant inhibition (up to 70%) of tumor growth in male nude mice bearing PC-3 tumors, associated with increased p27 levels and Bax level. Celastrol (3 mg/kg) results more apoptotic tumor cells with the appearance of various PARP cleavage fragments in tumor of male nude mice bearing PC-3 tumors. Celastrol (3 mg/kg) causes 35% of tumor inhibition, associated with decreased proteasome activity and decreased expression of AR protein in nude mice bearing C4-2B tumors. [1] Celastrol (3 mg/kg) is found to suppress strongly joint swelling and other manifestations of adjuvant arthritis in mice. Celastrol (0.2 mg/kg) significantly improves the performance in memory, learning and psychomotor activity tests in rats. [2]

Protocol (from reference)

Kinase Assay:[1]
  • Inhibition of purified 20S proteasome activity:

    A purified rabbit 20S proteasome (0.1 μg) is incubated with 40 μM of various fluorogenic peptide substrates in 100 μL assay buffer (20 mM Tris-HCl (pH 7.5)), in the presence of Celastrol at different concentrations or in the solvent DMSO for 2 hours at 37 ℃, followed by measurement of inhibition of each proteasomal activity.

Cell Research:[4]
  • Cell lines: RPMI 8226, KATOIII, UM-SCC1, U251MG and MDA-MB-231 cells
  • Concentrations: ~5 μM
  • Incubation Time: 2 hours
  • Method: The anti-proliferative effect of celastrol on various human tumor cell lines is determined by the MTT uptake method. Briefly, 5×103 cells are incubated with Celastrol in triplicate in a 96-well plate at 37 ℃. MTT solution is then added to each well. After a 2 hours incubation at 37 ℃, extraction buffer (20% SDS, 50% dimethylformamide) is added, cells are incubated overnight at 37 ℃, and the optical density is then measured at 570 nm using a Tecan plate reader.
Animal Research:[1]
  • Animal Models: nude mice bearing C4-2B tumors
  • Dosages: 3 mg/kg
  • Administration: Intraperitoneal injection

Solubility (25°C)

In vitro

Chemical Information

Molecular Weight 450.61
Formula

C29H38O4

CAS No. 34157-83-0
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CC1=C(C(=O)C=C2C1=CC=C3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C)O

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Celastrol (NSC 70931) | Celastrol (NSC 70931) supplier | purchase Celastrol (NSC 70931) | Celastrol (NSC 70931) cost | Celastrol (NSC 70931) manufacturer | order Celastrol (NSC 70931) | Celastrol (NSC 70931) distributor